Get the Stockscreener App
10.19
2.21%
-0.23
Pre-market:
10.19
Immatics N V stock is traded at $10.19, with a volume of 582.17K.
It is down -2.21% in the last 24 hours and up +19.60% over the past month.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.
See More
Previous Close:
$10.42
Open:
$10.41
24h Volume:
582.17K
Relative Volume:
0.69
Market Cap:
$1.24B
Revenue:
$58.49M
Net Income/Loss:
$-105.04M
P/E Ratio:
-7.8403
EPS:
-1.2997
Net Cash Flow:
$-13.78M
1W Performance:
+0.10%
1M Performance:
+19.60%
6M Performance:
+103.80%
1Y Performance:
+11.98%
1-Day Range:
$10.06
$10.63
1-Week Range:
$10.06
$10.87
52-Week Range:
$3.30
$11.25
Immatics N V Stock (IMTX) Company Profile
Compare IMTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IMTX
Immatics N V
|
10.19 | 1.27B | 58.49M | -105.04M | -13.78M | -1.2997 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Immatics N V Stock (IMTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-18-25 | Initiated | Guggenheim | Buy |
| May-28-25 | Initiated | Deutsche Bank | Buy |
| Oct-07-24 | Initiated | Piper Sandler | Overweight |
| Nov-02-23 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-31-23 | Initiated | Mizuho | Buy |
| Mar-24-23 | Initiated | Bryan Garnier | Buy |
| Nov-20-20 | Initiated | BofA Securities | Buy |
| Sep-22-20 | Initiated | Goldman | Buy |
| Jul-27-20 | Initiated | SVB Leerink | Outperform |
| Jul-24-20 | Initiated | Jefferies | Buy |
View All
Immatics N V Stock (IMTX) Latest News
Volatility clustering patterns for Immatics N.V. Equity WarrantM&A Rumor & Real-Time Volume Trigger Notifications - newser.com
Published on: 2025-11-03 01:38:22 - newser.com
How to build a custom watchlist for Immatics N.V. Equity WarrantDip Buying & Long-Term Capital Growth Strategies - newser.com
What analyst consensus says on Immatics N.V. stock2025 Analyst Calls & Free Real-Time Market Sentiment Alerts - newser.com
How Immatics N.V. (4A3) stock reacts to monetary easingJuly 2025 Breakouts & AI Powered Market Trend Analysis - newser.com
Is Immatics N.V. Equity Warrant reversing from oversold territoryAnalyst Downgrade & Safe Entry Trade Signal Reports - newser.com
Can Immatics N.V. stock hit analyst price targetsJuly 2025 WrapUp & Precise Entry and Exit Recommendations - newser.com
Can Immatics N.V. Equity Warrant hit a new high this monthDollar Strength & Weekly Stock Performance Updates - newser.com
Chart based analysis of Immatics N.V. Equity Warrant trendsWeekly Gains Summary & High Conviction Trade Alerts - newser.com
Published on: 2025-11-02 12:20:51 - newser.com
How Immatics N.V. stock responds to policy changesWeekly Trade Recap & Fast Moving Market Watchlists - newser.com
Published on: 2025-11-02 06:36:48 - newser.com
Published on: 2025-11-02 06:21:14 - newser.com
Order flow analysis tools used on Immatics N.V.July 2025 Market Mood & AI Based Buy/Sell Signal Reports - newser.com
Published on: 2025-11-02 03:46:01 - newser.com
Leading vs lagging indicators on Immatics N.V. performanceTreasury Yields & AI Powered Market Entry Ideas - newser.com
Developing predictive dashboards with Immatics N.V. Equity Warrant dataTrade Risk Assessment & Free High Return Stock Watch Alerts - newser.com
How resilient is Immatics N.V. Equity Warrant stock in market downturns2025 Year in Review & Free High Accuracy Swing Entry Alerts - newser.com
Can Immatics N.V. stock rebound after recent weaknessJuly 2025 Intraday Action & Daily Profit Focused Screening - newser.com
Why Immatics N.V. (4A3) stock appeals to dividend investorsMarket Sentiment Summary & AI Based Trade Execution Alerts - newser.com
Is a relief rally coming for Immatics N.V. holdersVolume Spike & AI Driven Price Forecasts - newser.com
How to track smart money flows in Immatics N.V.July 2025 Patterns & Fast Entry and Exit Trade Plans - newser.com
Will Immatics N.V. stock reach all time highs in 2025Options Play & Daily Growth Stock Tips - newser.com
Candlestick signals on Immatics N.V. stock todayWeekly Stock Summary & Daily Volume Surge Signals - newser.com
Analyzing Immatics N.V. with multi timeframe chartsTrade Entry Summary & Daily Entry Point Alerts - newser.com
Is Immatics N.V. Equity Warrant stock positioned for long term growthWeekly Profit Recap & Verified Trade Idea Suggestions - newser.com
Will Immatics N.V. stock outperform Dow Jones indexTrade Ideas & Weekly High Momentum Picks - newser.com
Why Immatics N.V. stock is a must watch in 2025Buy Signal & Stock Portfolio Risk Management - newser.com
Immatics N V Stock (IMTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.62%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):